213 related articles for article (PubMed ID: 28076842)
1. Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations.
Xu C; Qi R; Ping Y; Li J; Zhao H; Wang L; Du MY; Xiao Y; Li X
Oncotarget; 2017 Feb; 8(7):12041-12051. PubMed ID: 28076842
[TBL] [Abstract][Full Text] [Related]
2. LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions.
Xu C; Ping Y; Zhao H; Ning S; Xia P; Wang W; Wan L; Li J; Zhang L; Yu L; Xiao Y
Oncotarget; 2017 Dec; 8(70):114603-114612. PubMed ID: 29383105
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles.
Xu C; Ping Y; Li X; Zhao H; Wang L; Fan H; Xiao Y; Li X
Mol Biosyst; 2014 Nov; 10(11):2800-9. PubMed ID: 25099736
[TBL] [Abstract][Full Text] [Related]
4. Global Prioritizing Disease Candidate lncRNAs via a Multi-level Composite Network.
Yao Q; Wu L; Li J; Yang LG; Sun Y; Li Z; He S; Feng F; Li H; Li Y
Sci Rep; 2017 Jan; 7():39516. PubMed ID: 28051121
[TBL] [Abstract][Full Text] [Related]
5. Improved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data.
Wang P; Guo Q; Gao Y; Zhi H; Zhang Y; Liu Y; Zhang J; Yue M; Guo M; Ning S; Zhang G; Li X
Oncotarget; 2017 Jan; 8(3):4642-4655. PubMed ID: 27992375
[TBL] [Abstract][Full Text] [Related]
6. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks.
Walters K; Sarsenov R; Too WS; Hare RK; Paterson IC; Lambert DW; Brown S; Bradford JR
BMC Genomics; 2019 Jun; 20(1):454. PubMed ID: 31159744
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
9. A Novel Network-Based Computational Model for Prediction of Potential LncRNA⁻Disease Association.
Liu Y; Feng X; Zhao H; Xuan Z; Wang L
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925672
[TBL] [Abstract][Full Text] [Related]
10. Lnc2Catlas: an atlas of long noncoding RNAs associated with risk of cancers.
Ren C; An G; Zhao C; Ouyang Z; Bo X; Shu W
Sci Rep; 2018 Jan; 8(1):1909. PubMed ID: 29382910
[TBL] [Abstract][Full Text] [Related]
11. LDAI-ISPS: LncRNA-Disease Associations Inference Based on Integrated Space Projection Scores.
Zhang Y; Chen M; Li A; Cheng X; Jin H; Liu Y
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098405
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma.
Li Y; Wang Z; Wang Y; Zhao Z; Zhang J; Lu J; Xu J; Li X
Oncotarget; 2016 Jul; 7(29):45027-45041. PubMed ID: 26943771
[TBL] [Abstract][Full Text] [Related]
14. LncDisAP: a computation model for LncRNA-disease association prediction based on multiple biological datasets.
Wang Y; Juan L; Peng J; Zang T; Wang Y
BMC Bioinformatics; 2019 Dec; 20(Suppl 16):582. PubMed ID: 31787106
[TBL] [Abstract][Full Text] [Related]
15. LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies.
Xu Y; Li F; Wu T; Xu Y; Yang H; Dong Q; Zheng M; Shang D; Zhang C; Zhang Y; Li X
Oncotarget; 2017 Feb; 8(9):15453-15469. PubMed ID: 28152521
[TBL] [Abstract][Full Text] [Related]
16. Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network.
Zhang G; Pian C; Chen Z; Zhang J; Xu M; Zhang L; Chen Y
PLoS One; 2018; 13(5):e0196681. PubMed ID: 29715309
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.
Deng Y; Luo S; Zhang X; Zou C; Yuan H; Liao G; Xu L; Deng C; Lan Y; Zhao T; Gao X; Xiao Y; Li X
Mol Oncol; 2018 Nov; 12(11):1980-2005. PubMed ID: 30216655
[TBL] [Abstract][Full Text] [Related]
18. Identification of lncRNA Signature Associated With Pan-Cancer Prognosis.
Bao G; Xu R; Wang X; Ji J; Wang L; Li W; Zhang Q; Huang B; Chen A; Zhang D; Kong B; Yang Q; Yuan C; Wang X; Wang J; Li X
IEEE J Biomed Health Inform; 2021 Jun; 25(6):2317-2328. PubMed ID: 32991297
[TBL] [Abstract][Full Text] [Related]
19. Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network.
Zhou M; Wang X; Li J; Hao D; Wang Z; Shi H; Han L; Zhou H; Sun J
Mol Biosyst; 2015 Mar; 11(3):760-9. PubMed ID: 25502053
[TBL] [Abstract][Full Text] [Related]
20. Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features.
Zhao T; Xu J; Liu L; Bai J; Xu C; Xiao Y; Li X; Zhang L
Mol Biosyst; 2015 Jan; 11(1):126-36. PubMed ID: 25354589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
